PBPK Modeling Webinar
The application of physiologically based pharmacokinetic modeling (PBPK) has developed rapidly within the pharmaceutical industry and is becoming an integral part of drug discovery and development. PBPK models can provide a quantitative mechanistic framework for prediction of systemic and tissue exposures, and when combined with pharmacodynamic models can be used to estimate the time course of drug response for diverse dosing regimens in different species, populations, and disease states. This webinar, presented by Christopher Gibson, will review the recently published whitepaper describing the current state-of-the-art with respect to application of PBPK within the pharmaceutical industry.
11 AM Eastern Time, 18 September 2015